|
1
|
Wilkens S: Structure and mechanism of ABC
transporters. F1000Prime Rep. 7:142015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dean M, Hamon Y and Chimini G: The human
ATP-binding cassette (ABC) transporter superfamily. J Lipid Res.
42:1007–1017. 2001.PubMed/NCBI
|
|
3
|
Bodzioch M, Orsó E, Klucken J, Langmann T,
Böttcher A, Diederich W, Drobnik W, Barlage S, Büchler C,
Porsch-Ozcürümez M, et al: The gene encoding ATP-binding cassette
transporter 1 is mutated in Tangier disease. Nat Genet. 22:347–351.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brooks-Wilson A, Marcil M, Clee SM, Zhang
LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO,
et al: Mutations in ABC1 in Tangier disease and familial
high-density lipoprotein deficiency. Nat Genet. 22:336–345. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Allikmets R, Singh N, Sun H, Shroyer NF,
Hutchinson A, Chidambaram, Gerrard B, Baird L, Stauffer D, Peiffer
A, et al: A photoreceptor cell-specific ATP-binding transporter
gene (ABCR) is mutated in recessive Stargardt macular dystrophy.
Nat Genet. 15:236–246. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bergen AA, Plomp AS, Schuurman EJ, Terry
S, Breuning M, Dauwerse H, Swart J, Kool M, van Soest S, Baas F, et
al: Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet.
25:228–231. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Riordan JR, Rommens JM, Kerem B, Alon N,
Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et
al: Identification of the cystic fibrosis gene: Cloning and
characterization of complementary DNA. Science. 245:1066–1073.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kartner N, Riordan JR and Ling V: Cell
surface P-glycoprotein associated with multidrug resistance in
mammalian cell lines. Science. 221:1285–1288. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cole SP: Multidrug resistance protein 1
(MRP1, ABCC1), a 'multitasking' ATP-binding cassette (ABC)
transporter. J Biol Chem. 289:30880–30888. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mo W and Zhang JT: Oligomerization of
human ATP-binding cassette transporters and its potential
significance in human disease. Expert Opin Drug Metab Toxicol.
5:1049–1063. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jetté L, Potier M and Béliveau R:
P-glycoprotein is a dimer in the kidney and brain capillary
membranes: Effect of cyclosporin A and SDZ-PSC 833. Biochemistry.
36:13929–13937. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Soszyński M, Kałuzna A, Rychlik B, Sokal A
and Bartosz G: Radiation inactivation suggests that human multidrug
resistance-associated protein 1 occurs as a dimer in the human
erythrocyte membrane. Arch Biochem Biophys. 354:311–316. 1998.
View Article : Google Scholar
|
|
13
|
Ramjeesingh M, Kidd JF, Huan LJ, Wang Y
and Bear CE: Dimeric cystic fibrosis transmembrane conductance
regulator exists in the plasma membrane. Biochem J. 374:793–797.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Albrecht C and Viturro E: The ABCA
subfamily - gene and protein structures, functions and associated
hereditary diseases. Pflugers Arch. 453:581–589. 2007. View Article : Google Scholar
|
|
15
|
Denis M, Haidar B, Marcil M, Bouvier M,
Krimbou L and Genest J: Characterization of oligomeric human ATP
binding cassette transporter A1. Potential implications for
determining the structure of nascent high density lipoprotein
particles. J Biol Chem. 279:41529–41536. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ban N, Matsumura Y, Sakai H, Takanezawa Y,
Sasaki M, Arai H and Inagaki N: ABCA3 as a lipid transporter in
pulmonary surfactant biogenesis. J Biol Chem. 282:9628–9634. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matsumura Y, Sakai H, Sasaki M, Ban N and
Inagaki N: ABCA3-mediated choline-phospholipids uptake into
intracellular vesicles in A549 cells. FEBS Lett. 581:3139–3144.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shulenin S, Nogee LM, Annilo T, Wert SE,
Whitsett JA and Dean M: ABCA3 gene mutations in newborns with fatal
surfactant deficiency. N Engl J Med. 350:1296–1303. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bullard JE, Wert SE, Whitsett JA, Dean M
and Nogee LM: ABCA3 mutations associated with pediatric
interstitial lung disease. Am J Respir Crit Care Med.
172:1026–1031. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Campo I, Zorzetto M, Mariani F, Kadija Z,
Morbini P, Dore R, Kaltenborn E, Frixel S, Zarbock R, Liebisch G,
et al: A large kindred of pulmonary fibrosis associated with a
novel ABCA3 gene variant. Respir Res. 15:432014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Weichert N, Kaltenborn E, Hector A,
Woischnik M, Schams A, Holzinger A, Kern S and Griese M: Some ABCA3
mutations elevate ER stress and initiate apoptosis of lung
epithelial cells. Respir Res. 12:42011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Engelbrecht S, Kaltenborn E, Griese M and
Kern S: The surfactant lipid transporter ABCA3 is N-terminally
cleaved inside LAMP3-positive vesicles. FEBS Lett. 584:4306–4312.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gersting SW, Lotz-Havla AS and Muntau AC:
Bioluminescence resonance energy transfer: An emerging tool for the
detection of protein-protein interaction in living cells. Methods
Mol Biol. 815:253–263. 2012. View Article : Google Scholar
|
|
24
|
Matsumura Y, Ban N, Ueda K and Inagaki N:
Characterization and classification of ATP-binding cassette
transporter ABCA3 mutants in fatal surfactant deficiency. J Biol
Chem. 281:34503–34514. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bischof JC and He X: Thermal stability of
proteins. Ann NY Acad Sci. 1066:12–33. 2005. View Article : Google Scholar
|
|
26
|
Hamdan FF, Percherancier Y, Breton B and
Bouvier M: Monitoring protein-protein interactions in living cells
by biolu-minescence resonance energy transfer (BRET). Curr Protoc
Neurosci. Chapter 5, Unit 5.23. 2006. View Article : Google Scholar
|
|
27
|
Nylander S and Kalies I: Brefeldin A, but
not monensin, completely blocks CD69 expression on mouse
lymphocytes: Efficacy of inhibitors of protein secretion in
protocols for intracellular cytokine staining by flow cytometry. J
Immunol Methods. 224:69–76. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Trompier D, Alibert M, Davanture S, Hamon
Y, Pierres M and Chimini G: Transition from dimers to higher
oligomeric forms occurs during the ATPase cycle of the ABCA1
transporter. J Biol Chem. 281:20283–20290. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Heuberger EH, Veenhoff LM, Duurkens RH,
Friesen RH and Poolman B: Oligomeric state of membrane transport
proteins analyzed with blue native electrophoresis and analytical
ultra-centrifugation. J Mol Biol. 317:591–600. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matsumoto N, Tamura S, Furuki S, Miyata N,
Moser A, Shimozawa N, Moser HW, Suzuki Y, Kondo N and Fujiki Y:
Mutations in novel peroxin gene PEX26 that cause
peroxisome-biogenesis disorders of complementation group 8 provide
a genotype-phenotype correlation. Am J Hum Genet. 73:233–246. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fitzgerald ML, Okuhira K, Short GF III,
Manning JJ, Bell SA and Freeman MW: ATP-binding cassette
transporter A1 contains a novel C-terminal VFVNFA motif that is
required for its cholesterol efflux and ApoA-I binding activities.
J Biol Chem. 279:48477–48485. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang S, Yue H, Derin RB, Guggino WB and Li
M: Accessory protein facilitated CFTR-CFTR interaction, a molecular
mechanism to potentiate the chloride channel activity. Cell.
103:169–179. 2000. View Article : Google Scholar : PubMed/NCBI
|
